Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer

BACKGROUND: Solute Carrier Family 6 Member 1 (SLC6A1) has been identified as a cancer-promoting gene in various human cancers, such as clear cell renal cell carcinoma and ovarian cancer. However, its roles in prostate cancer (PCa) has not been fully elucidated. The aim of this study was to investiga...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Chen, Chaojiang, Cai, Zhiduan, Zhuo, Yangjia, Xi, Ming, Lin, Zhuoyuan, Jiang, Funeng, Liu, Zezhen, Wan, Yueping, Zheng, Yu, Li, Jianxin, Zhou, Xing, Zhu, Jianguo, Zhong, Weide
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7137497/
https://ncbi.nlm.nih.gov/pubmed/32252682
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-020-06776-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados